On September 11, 2025, FOXO Technologies Inc. announced a stock purchase agreement to acquire Vector Biosource Inc., a provider in the biotechnology sector. This filing indicates a strategic move to enhance its capabilities in data and biospecimen sourcing for the clinical research industry.